Recommended

Subscribers

Sign in now to see personalised content appear here.

You can also see your reading history and subscription details on your subscriber page.

Why subscribe?
Find out more.

Sign up for your FREE email newsletter  +

New

Osteoporosis romosozumab

Osteoporosis occurs when the rate at which new bone is being made is slower than the rate at which it is lost, with the bones becoming more prone to fracture

Regulatory | R and D | Therapeutic Sector | Orthopaedics

Amgen and Astellas agree alliance in Japan

Will focus on co-development of five Amgen medicines in Japan

North America | R and D | Biotechnology | Therapeutic Sector | Asia | Cardiology | Orthopaedics

Gout pegloticase

Drugs such as allopurinol and probenecid can be used to reduce uric acid levels, but do not work in all patients

Regulatory | R and D | Therapeutic Sector | Orthopaedics

Japanese regulator approves osteoporosis jelly

Teijin Pharma plans to launch first oral jelly for osteoporosis later this year

Therapeutic Sector | Asia | Orthopaedics

Fujifilm Kyowa Kirin Biologics starts operations

The jv between Fujifilm and Kyowa Hakko Kirin will develop, manufacture and sell biosimilars

Biotechnology | Therapeutic Sector | Finance | Asia | Manufacturing | Orthopaedics

In the Press